[Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
Berenguer Sánchez
Antonio
A
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens; D000951:Antigens, Neoplasm / Q000097:blood; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D004967:Estrogens / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D008297:Male; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009919:Orchiectomy; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000726:Androgen Antagonists; D000728:Androgens; D000951:Antigens, Neoplasm; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone; D017430:Prostate-Specific Antigen